Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

In just one week, Secaucus-based Quest Diagnostics announced two new product offerings: one for at-home consumer use and another for physicians. The consumer product, Genetic Insights, helps people ...

PHILADELPHIA -- Quest Diagnostics is rolling out an antibody test consumers can order online before ever going to the doctor's office. The test is supposed to show whether someone has had or has been ...

Exposed or experiencing symptoms of COVID-19, but don’t want to risk going to a testing site? Secaucus-based Quest Diagnostics on Thursday said it launched a new, U.S. Food and Drug ...

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif. and ...

May enhance evaluation of cancer risk in the up to 1.5 million women who receive an indeterminate Pap test result each year MADISON, N.J., Aug. 30, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), ...

Quest’s two AD-Detect blood-based tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer’s disease pathology in ...

Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more frequent screenings using technology developed at the MD Anderson Cancer Center ...

Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect™ product line for assessing symptomatic patients SECAUCUS, N.J., July 9, ...

The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic ...